-
October mARKet Update Webinar
October mARKet update Spotlight: Undervalued Equity Markets, Direct-to-Consumer Genetic Testing, & Late-Stage Venture Capital ‘mARKet update’ | What We Discovered This Month We invite you to join our 30-minute monthly webinar series presented by ARK’s Chief Investment Officer, Catherine D. Wood, and her teams of thematic analysts. The webinar offers a Q&A-based discussion on […]
August mARKet Update Webinar
August mARKet update Spotlight: Inverted Yield Curves, Illumina vs. Invitae, and Square’s Cash App. ‘mARKet update’ | What We Discovered This Month We invite you to join our 30-minute monthly webinar series presented by ARK’s Chief Investment Officer, Catherine D. Wood, and her teams of thematic analysts. The webinar offers a Q&A-based discussion on […]
June mARKet Update Webinar
June mARKet update Spotlight: ARK’s Latest White Paper, Digital Wallet Companies, and Liquid Biopsies. ‘mARKet update’ | What We Discovered This Month We invite you to join our 30-minute monthly webinar series presented by ARK’s Chief Investment Officer, Catherine D. Wood, and her teams of thematic analysts. The webinar offers a Q&A-based discussion on […]
Immunotherapy Part 2, with Dr. Daniel Chen MD PhD
On today’s show we welcome Dr. Daniel Chen MD PhD, formerly Vice President, Global Head of Cancer Immunotherapy at Genentech/Roche and now Chief Medical Officer at IGM Biosciences to continue our current exploration of immunotherapy in the fight against cancer. In April we spoke to Charles Graeber, author of The Breakthrough, and today we are […]
How Liquid Biopsies Will Become a Standard in Recurrence Monitoring
Conventional guidelines for monitoring the recurrence of cancer involve routine physical exams and medical imaging. Recurrent tumors often are aggressive, especially if they appear in locations different from those in the original diagnoses. Yet, while PET and CT scans can surface important information about existing tumors, they rarely detect emerging tumors which, with time, can […]
March mARKet Update Webinar
March mARKet update Spotlight: a late 1990’s comparison, JPM Coin, the FDA’s modernization efforts, and more. ‘mARKet update’ | What We Discovered This Month We invite you to join our 30-minute monthly webinar series presented by ARK’s Chief Investment Officer, Catherine D. Wood, and her teams of thematic analysts. The webinar offers a Q&A-based […]
Liquid Biopsies to Detect Cancer Could Boost Annual Sequencing Volume By 40-Fold
Mentioned Companies: GHNext-generation DNA sequencing (“NGS”) is creating a new wave of diagnostic tests for cancer. The level of detail offered by NGS tools is helping researchers make important connections between the biology of tumors and the successful treatment of cancer. Cancer is a dynamic and elusive disease. Its genetic profile mutates over time, sometimes in response […]
December mARKet Update Webinar
December mARKet update Spotlight: The Wall of Worry, Bitcoin’s Mining Death Spiral, CRISPR-Modified Babies, and Translating Genetic Data. ‘mARKet update’ | What We Discovered This Month We invite you to join our 30-minute monthly webinar series presented by ARK’s Chief Investment Officer, Catherine D. Wood, and her teams of thematic analysts. The webinar offers […]
ARK Disrupt Issue 141: EVs, Nodes, Servers, Fintech, & Gene Editing
Please enjoy ARK Disrupt Issue 141. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 138: GPUs, Crypto, Fintech, Mobility, and Disease
Please enjoy ARK Disrupt Issue 138. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 131: Cryptoassets, AI, Fintech, Robots, Autonomous Cars, and Genes
Please enjoy ARK Disrupt Issue 131. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 130: IGTV, Venmo, Electric Vehicles, Industrial Robots, and DNA Storage
Please enjoy ARK Disrupt Issue 130. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 126: Autonomous Vehicles, CRISPR, & Blockchain Technology
Please enjoy ARK Disrupt Issue 126. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 125: Autonomous Vehicles, DNA Sequencing, Deep Learning, & Fintech
Please enjoy ARK Disrupt Issue 125. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 124: 3D Printing, Tesla, Google Duplex, Fintech, & CRISPR
Please enjoy ARK Disrupt Issue 124. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
May mARKet Update Webinar
May mARKet update Spotlight: Market Review, the yield curve, and companies investing in the future. ‘mARKet update’ | What We Discovered This Month We invite you to join our 30-minute monthly webinar series presented by ARK’s Chief Investment Officer, Catherine D. Wood, and her teams of thematic analysts. The webinar offers a Q&A-based discussion […]
ARK Disrupt Issue 123: Batteries, Semiconductors, Fintech, & Cells
Please enjoy ARK Disrupt Issue 123. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 122: Subscription Models, Remittances, & CRISPR
Please enjoy ARK Disrupt Issue 122. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 121: AI Chips, Payments, Autos, & Cells
Please enjoy ARK Disrupt Issue 121. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 120: EVs, LiDAR, Privacy & Data, Fintech, & CRISPR
Please enjoy ARK Disrupt Issue 120. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 116: Gaming, Blockchain Technology, Autonomous Vehicles, & CRISPR
Please enjoy ARK Disrupt Issue 116. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 112: Electric Vehicles, GPUs, and CRISPR
Please enjoy ARK Disrupt Issue 112. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 111: Autonomous Technology, Deep Learning, and Lab Grown Meat
Please enjoy ARK Disrupt Issue 111. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 108: CRISPR, Electric Vehicles, Blockchain Technology, and Crypto Mining
Please enjoy ARK Disrupt Issue 108. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 107: Deep Learning, Ripple, CRISPR, and CES
Please enjoy ARK Disrupt Issue 107. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
January mARKet Update
January mARKet update Spotlight: Questions Concerning the Market Today, the Genomic Revolution, and more… ‘mARKet update’ | What We Discovered This Month We invite you to join our 30-minute monthly webinar series presented by ARK’s Chief Investment Officer, Catherine D. Wood, and her teams of thematic analysts. The webinar offers a Q&A-based discussion on […]
Big Ideas 2018
Since our founding in 2014, ARK Invest has had one focus: Disruptive Innovation. We define disruptive innovation as the introduction of a technologically enabled new product or service that is going to change the way the world works and make it a better place. Seeking to educate investors and innovation enthusiasts, ARK decided to publish […]
ARK Disrupt Issue 106: Hybrid Vehicles, Cybersecurity, Blockchain Technology, and CAR-T Therapy
Please enjoy ARK Disrupt Issue 106. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 105: Autonomous Cars, Electric Vehicles, Bitcoin, Insur-Tech, and Blockchain Technology
Please enjoy ARK Disrupt Issue 105. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 104: Autonomous Cars, Electric Vehicles, Cryptoassets, and CAR-T Therapies
Please enjoy ARK Disrupt Issue 104. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 103: Autonomous Taxis, Flying Cars, AI, Bitcoin, and CRISPR
Please enjoy ARK Disrupt Issue 103. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 102: Autonomous EVs, Bitcoin, AI, Gene Editing, and Israel
Please enjoy ARK Disrupt Issue 102. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 97: Electric Vehicles, Artificial Intelligence, Bitcoin, and CRISPR
Please enjoy ARK Disrupt Issue 97. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 96: Online Auto Sales, Autonomous Cars, Self-Driving Computers, Fintech, and CRISPR
Please enjoy ARK Disrupt Issue 96. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 95: EVs, Autonomous Taxis, Cryptocurrency, and CRISPR
Please enjoy ARK Disrupt Issue 95. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 94: SpaceX, Autonomous Cars, Amazon, Artificial Intelligence, and the Microbiome Space
Please enjoy ARK Disrupt Issue 94. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 93: Autonomous Chips, CRISPR, Mobile Chips, and Bitcoin Mining
Please enjoy ARK Disrupt Issue 93. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 92: AI, Blockchain, CRISPR, Drones, and EVs
Please enjoy ARK Disrupt Issue 92. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
Gene-Editing Could Modify and Cure Disease: CRISPR vs. TALENs
Genome-Editing During the past decade, technology breakthroughs enabling the modification of complex genomes have changed the primary goal of research in biotechnology and synthetic biology: now research is focused not on “treatment” of diseases but on its modification and cure. The ability to directly edit living cells has brought gene therapy and precision medicine into […]
ARK Disrupt Issue 91: The Equifax Hack, AI, Payments, CRISPR, and The Self Drive Act Bill
Please enjoy ARK Disrupt Issue 91. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 89: Autonomous Vehicles, Battery Packs, Bitcoin, Blockchain, and CRISPR
Please enjoy ARK Disrupt Issue 89. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 86: Genome-Editing, Bitcoin, Fintech, and Autos
Please enjoy ARK Disrupt Issue 86. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 84: AI, ICOs, Dashcams, and CRISPR
Please enjoy ARK Disrupt Issue 84. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 83: AI, Fintech, Autonomous EVs, and Cancer Breakthroughs
Please enjoy ARK Disrupt Issue 83. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
The Stem Cell Revolution
Discovered nearly thirty years ago in 1988[1], stem cell technology has failed to transform the field of regenerative medicine…until now. After delivering only one treatment during three decades of development, stem cell technology could finally become the all-purpose tool for repairing the body, thanks to rapid and precise genome editing techniques such as CRISPR and […]
Big Ideas 2017
Rooted in almost 40 years of experience, ARK Invest aims to identify large-scale investment opportunities resulting from technological change. We believe innovation is key to growth. From a broad spectrum of disruptive innovations, Big Ideas represents our annual breakout of technologies that we believe will accelerate significantly in the months ahead. Each section provides you with a brief introduction before illustrating […]
ARK Disrupt Issue 75: Deep Learning, Micro-Finance, Ethereum, Autonomous Taxi Networks, and Stem Cells
Please enjoy ARK Disrupt Issue 75. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 74: Deep Learning, Genomics, Solar, and Fintech
Please enjoy ARK Disrupt Issue 74. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 62: AI, Fintech, Internet Access, and Genome Editing
Please enjoy ARK Disrupt Issue 62. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Disrupt Issue 61: Automation, Robotics, Machine Learning, and Bitcoin
Please enjoy ARK Disrupt Issue 61. This blog series is based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders, and investors. It is designed to present you with the most recent innovation takeaways and to keep you engaged in an ongoing discussion on investing in […]
ARK Brainstorming: Insights on Tesla, Snapchat, and AquaBounty
This is a blog series based on ARK Brainstorming, a weekly discussion between our CEO, Director of Research, thematic analysts, ARK’s theme developers, thought leaders and investors. It is designed to keep you engaged in an ongoing discussion on disrupitve innovation. 1. Will Tesla’s Model 3 Include Quanergy LiDAR? Recently, a Tesla owner spotted a […]
Illumina Is the Bedrock of the Genomic Revolution
Mentioned Companies: ILMNIllumina is the cornerstone of our Genomic Revolution theme, and one of our highest conviction stocks. In response to an earnings preannouncement this week, it dropped as much as 25% in one day. While investors fear that it has passed its fastest growth rate, in our view Illumina is leading a genomic revolution that has […]
On-site Cancer Tests Can Increase Survival Rates
Patients with pancreatic cancer have a 35% chance of dying before their molecular diagnostic test results return from the lab. At roughly a 23-29% chance, lung, brain, and stomach cancer patients have only marginally better odds of surviving to see the results, as shown below. Precision medicine enables personalized diagnoses and directs molecular treatments. Companies […]
Heading for $100: The Declining Costs of Genome Sequencing & The Consequences
The Human Genome Project (HGP), the first whole human genome sequencing in 2000, cost over $3.7 billion and took 13 years of computing power. Today, it costs roughly $1,000 and takes fewer than three days. With trillions of genomes waiting to be sequenced, both human and otherwise, the genomic revolution is in its infancy. Since […]
Agricultural Biotechnology: The First Genomic Industry
Can you believe that in 2014, $160 billion worth of corn will be grown on land that theoretically could produce $560 billion? By producing and delivering seeds precisely designed for the square meter of earth in which they will be grown genetic engineering will narrow this gap. As illustrated below, global corn yields are roughly half of what they are in the US alone, and US yields are a bit less than half of what is theoretically possible today.
Investing in the Bioinformatic Space: It’s not just the Software – Hardware Counts, too
The declining cost of sequencing a human genome (in some instances, for as little as $1,000 per sequence) is creating a growing demand for tools that can sort, organize, analyze, and store the ever-increasing amount of biological data. If properly harnessed, data can be used for academic research and by pharmaceutical and diagnostic industries.
The Prosthetics Market: Will Genomic Solutions Preempt Significant Growth?
Unlike most other areas of health care, prosthetics has improved very little since its inception during the American Civil War when the first documented amputee founded Hanger Inc . Radical change, however, may be under way. Current prosthetics offer little functionality. Amputees often discontinue their use for several reasons, including discomfort and inconvenience. In addition, senior citizens […]
The Veracyte Afirma Test: A Case Study for the Promise & Need of Molecular Diagnostics
Advancements in molecular diagnostics can prevent unnecessary surgical procedures, reducing healthcare costs and improving patients’ wellbeing. In the United States, doctors perform approximately 25,000 unnecessary thyroid surgeries annually. Following the discovery of a lump in the throat, doctors typically recommend removal before receiving results of fine needle aspiration (FNA), isolating the risk of cancer. More […]
Spell-Checking the Language of Life: CRISPR Gene Editing In Living Animals
Repairing a genetic mutation could eliminate a lifetime of suffering. Until recently, the only option was gene therapy, which many perceive as risky. Recent successes in gene therapy and new advances in gene editing technology may mean doctors and patients will have many options. Researchers have worked for years to devise techniques to surmount the challenges […]
An Oasis in the Wasteland: Can In-Silico Drug Discovery Help Save Pharma?
Advances in algorithmic science and cloud computing could increase the success rate of drug discovery in the pharmaceutical industry, while considerably reducing costs. Given the size of R&D spending in the pharmaceutical industry, and its current low success rate, the positive impact on profits could be dramatic. Over the past ten years the pharmaceutical industry […]
